RainMed Medical Inc.

Founded in 2014, RainMed Medical is committed to becoming the world's leading panvascular interventional robotics company. Currently, it focusing on the design, development and commercialization of coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microcirculatory resistance (caIMR) systems. With independent innovation and great efforts, RainMed Medical has gradually built up a global R&D, production, sales and service network. RainMed Medical has actively cooperated with top medical centers and experts at home and abroad to build a perfect patent system. Many research results are continuously published in authoritative journals such as “Cardiovascular Research” and “JACC: Cardiovascular Interventions”. In addition, the company has signed strategic cooperation agreements with many top medical device distribution service platforms in China, developed a strict quality inspection system and perfect supply process, and successfully passed the medical device quality management system certification.